The stimulator of interferon genes (STING) cellular signaling pathway is a promising target
for cancer immunotherapy. Activation of the intracellular STING protein triggers the …

Nanotechnology in medical applications, especially in oncology as drug delivery systems,
has recently shown promising results. However, although these advances have been …

The need for long-term treatments of chronic diseases has motivated the widespread
development of long-acting parenteral formulations (LAPFs) with the aim of improving drug …

Despite advances in breast cancer treatments and related 5-year survival outcomes,
metastatic breast cancer cures remain elusive. The current standard of care includes a …

In spite of introduction of combination antiretroviral therapy (cART) against human
immunodeficiency virus (HIV) infection; inaccessibility and poor adherence to oral cART …

High-efficiency cancer treatment remains the main challenge at present. In this study, a
mesoporous platinum nanoparticle-(mesoPt) based nanoplatform is exported for effective …

Nanoemulsions (NEs) of essential oil (EO) have significant potential to target
microorganisms, especially viruses. They act as a vehicle for delivering antiviral drugs and …

Systemic administration of chemotherapeutics by nanocarriers (NCs) functionalized with
targeting agents provides a localized accumulation of drugs in the target tissues and cells …

Antiretroviral therapy has transformed human immunodeficiency virus infections from certain
death to a manageable chronic disease. Achieving strict adherence to drug regimens that …

Complex diseases such as cancer and microbial infections are multifactorial in nature with
numerous redundant signalling pathways involved in the disease development.[1–3] …